# Paper Applicator Acceptability Study

> **NCT02179138** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **CONRAD**

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** TFV 1% gel

## Key facts

- **NCT ID:** NCT02179138
- **Lead sponsor:** CONRAD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study no longer relevant based on change in regulatory pathway for TFV 1% gel
- **Last updated:** 2015-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179138, "Paper Applicator Acceptability Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02179138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*